Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make a certain notification more than once.
Bill File Type: Regular
Effective Date(s): October 1, 2020
( 21-2A-02, 21-2A-04.2 )
Last Updated: 9/22/2020 2:44 PM